Published in Circulation on October 01, 1976
Left ventricular dyssynchrony in pre-excitation syndrome: effect of accessory pathway location and reversibility after ablation therapy. Heart Vessels (2012) 1.07
Improvement in non-tachycardia-induced cardiac failure after radiofrequency catheter ablation in a child with a right-sided accessory pathway. Heart Vessels (2013) 0.87
The use of echocardiography in Wolff-Parkinson-White syndrome. Int J Cardiovasc Imaging (2011) 0.82
Echocardiographic investigation of the mechanism underlying abnormal interventricular septal motion after open heart surgery. J Cardiovasc Ultrasound (2014) 0.81
Noninvasive assessment of left ventricular function in myotonic muscular dystrophy. Br Heart J (1978) 0.79
Reversion of left ventricular systolic dysfunction and abnormal stress test: by catheter ablation, in a patient with Wolff-Parkinson-White syndrome from Para-Hisian Kent bundle. Tex Heart Inst J (2010) 0.75
Global and regional left ventricular contractile impairment in patients with wolff-Parkinson-white syndrome. Indian Pacing Electrophysiol J (2009) 0.75
Ventricular dyssynchrony and function improve following catheter ablation of nonseptal accessory pathways in children. Biomed Res Int (2013) 0.75
Dyssynchronous ventricular contraction in Wolff-Parkinson-White syndrome: a risk factor for the development of dilated cardiomyopathy. Eur J Pediatr (2013) 0.75
Accessory pathway location affects brain natriuretic peptide level in patients with Wolff-Parkinson-White syndrome. J Interv Card Electrophysiol (2016) 0.75
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature (1998) 21.49
Antisense transcription in the mammalian transcriptome. Science (2005) 15.69
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet (2000) 7.83
Delineating developmental and metabolic pathways in vivo by expression profiling using the RIKEN set of 18,816 full-length enriched mouse cDNA arrays. Proc Natl Acad Sci U S A (2001) 6.07
An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell (2001) 4.41
Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Science (2001) 4.18
Endoscopic papillary balloon dilation for the management of common bile duct stones: experience of 226 cases. Endoscopy (1998) 4.11
Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy. Science (1995) 3.66
Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc Natl Acad Sci U S A (1996) 2.88
Substance use and sexual transmission risk behavior of HIV-positive men who have sex with men. J Subst Abuse (2001) 2.56
Beta-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nat Genet (1995) 2.53
Protein-bound acrolein: potential markers for oxidative stress. Proc Natl Acad Sci U S A (1998) 2.42
Inclusion of the transcervical approach in video-assisted thoracoscopic extended thymectomy (VATET) for myasthenia gravis: a prospective trial. Surg Endosc (2006) 2.39
Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q. Neurology (1998) 2.37
Anomalous criticality in the electrical resistivity of La2-xSrxCuO4. Science (2008) 2.15
Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease. Biochem Biophys Res Commun (1996) 2.09
An index of disease activity in patients with ulcerative colitis. Am J Gastroenterol (1992) 1.99
Risk factors for hemorrhage from gastric fundal varices. Hepatology (1997) 1.92
Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. Circulation (1999) 1.89
Immunohistochemical and subcellular localization of Parkin protein: absence of protein in autosomal recessive juvenile parkinsonism patients. Ann Neurol (1999) 1.86
Reciprocal group I inhibition on triceps surae motoneurons in man. J Neurophysiol (1971) 1.81
Resources, stigma, and patterns of disclosure in rural women with HIV infection. Public Health Nurs (1997) 1.76
Decrease of CD56(+)T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma. Hepatology (2000) 1.71
Point mutations in mitochondrial tRNA genes: sequence analysis of chronic progressive external ophthalmoplegia (CPEO) J Neurol Sci (1994) 1.65
Extra-long first-strand cDNA synthesis. Biotechniques (2002) 1.64
Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal-arginine adducts. J Biol Chem (1999) 1.64
CD45 regulates Src family member kinase activity associated with macrophage integrin-mediated adhesion. Curr Biol (1997) 1.63
Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J (1999) 1.62
Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson's disease. Eur J Neurol (2012) 1.57
Crystal structure of ribonuclease H from Thermus thermophilus HB8 refined at 2.8 A resolution. J Mol Biol (1993) 1.57
Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients. Gut (2005) 1.54
Polymorphism in the parkin gene in sporadic Parkinson's disease. Ann Neurol (1999) 1.52
Hypercalcaemia caused by all-trans retinoic acid treatment of acute promyelocytic leukaemia: case report. Eur J Haematol (1994) 1.52
Predominant activation and expansion of V gamma 9-bearing gamma delta T cells in vivo as well as in vitro in Salmonella infection. J Clin Invest (1992) 1.52
Paramagnetic water-soluble metallofullerenes having the highest relaxivity for MRI contrast agents. Bioconjug Chem (2001) 1.50
Migration of enhanced green fluorescent protein expressing bone marrow-derived microglia/macrophage into the mouse brain following permanent focal ischemia. Neuroscience (2003) 1.50
From dystrophinopathy to sarcoglycanopathy: evolution of a concept of muscular dystrophy. Muscle Nerve (1998) 1.48
MicroRNA-mediated downregulation of mTOR/FGFR3 controls tumor growth induced by Src-related oncogenic pathways. Oncogene (2011) 1.48
Crystal structure of Escherichia coli RNase HI in complex with Mg2+ at 2.8 A resolution: proof for a single Mg(2+)-binding site. Proteins (1993) 1.46
Primary hepatic carcinoid and neuroendocrine carcinoma: clinicopathological and immunohistochemical study of five cases. Pathol Int (1999) 1.44
Localization of a gene for an autosomal recessive form of juvenile Parkinsonism to chromosome 6q25.2-27. Am J Hum Genet (1997) 1.43
Surgical rescue for life-threatening hypoxemia caused by a mediastinal tumor. Ann Thorac Surg (1999) 1.43
Type 3 GM1 gangliosidosis: clinical and neuroradiological findings in an 11-year-old girl. J Neurol (1995) 1.42
Spherical crystallization: direct spherical agglomeration of salicylic Acid crystals during crystallization. Science (1982) 1.42
Histochemical detection of apoptosis in Parkinson's disease. J Neurol Sci (1996) 1.42
Can beta-blocker therapy be withdrawn from patients with dilated cardiomyopathy? Am Heart J (1999) 1.41
Relationship of renal histological damage to glomerular hypertension in patients with immunoglobulin A nephropathy. J Hypertens (2000) 1.40
Levodopa: why the controversy? Lancet (2002) 1.39
Molecular organization at the glycoprotein-complex-binding site of dystrophin. Three dystrophin-associated proteins bind directly to the carboxy-terminal portion of dystrophin. Eur J Biochem (1994) 1.38
[Amnestic syndrome with bilateral lesions restricted to the field CA-1 of both hippocampi--a case report with CT and MRI findings]. Rinsho Shinkeigaku (1991) 1.37
Evaluation of a simple loop-mediated isothermal amplification test kit for the diagnosis of tuberculosis. Int J Tuberc Lung Dis (2011) 1.37
Dissociation of the complex of dystrophin and its associated proteins into several unique groups by n-octyl beta-D-glucoside. Eur J Biochem (1994) 1.33
Molecular characterization of type-specific capsular polysaccharide biosynthesis genes of Streptococcus agalactiae type Ia. J Bacteriol (1999) 1.32
Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease. Ann Neurol (1991) 1.32
Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome, Creutzfeldt-Jakob disease and scrapie. Lab Invest (1990) 1.32
Accelerating effects of chitosan for healing at early phase of experimental open wound in dogs. Biomaterials (1999) 1.31
Structure of wye (Yt base) and wyosine (Yt) from Torulopsis utilis phenylalanine transfer ribonucleic acid. Biochemistry (1976) 1.30
Dystrophin-associated proteins in muscular dystrophy. Hum Mol Genet (1995) 1.28
Associations of medical status and physical fitness with periodontal disease. J Clin Periodontol (1999) 1.28
Isolation and characterization of a mannan-binding protein from rat liver. J Biol Chem (1981) 1.28
Do variations in hip geometry explain differences in hip fracture risk between Japanese and white Americans? J Bone Miner Res (1994) 1.26
Transient ventricular wall thickening in acute myocarditis: a serial echocardiographic and histopathologic study. Jpn Circ J (2001) 1.25
Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells. Immunology (2001) 1.25
The effectiveness of coping strategies used by HIV-seropositive women. Res Nurs Health (1998) 1.25
Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study. Diabetes Care (2001) 1.24
Clinical spectrum of congenital cystic disease of the lung in children. Eur J Cardiothorac Surg (1999) 1.24
Biochemical evidence for association of dystrobrevin with the sarcoglycan-sarcospan complex as a basis for understanding sarcoglycanopathy. Hum Mol Genet (2000) 1.23
Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease. J Neural Transm Park Dis Dement Sect (1992) 1.23
Inhibition of mitochondrial NADH-ubiquinone oxidoreductase activity by 1-methyl-4-phenylpyridinium ion. Biochem Biophys Res Commun (1987) 1.23
PARK6-linked autosomal recessive early-onset parkinsonism in Asian populations. Neurology (2004) 1.22
Comparison of the risk factors for coronary artery spasm with those for organic stenosis in a Japanese population: role of cigarette smoking. Int J Cardiol (2000) 1.22
Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease. Neurosci Lett (1999) 1.21
A clinical and pathologic study of a large Japanese family with Machado-Joseph disease tightly linked to the DNA markers on chromosome 14q. Neurology (1994) 1.21
Serum concentrations of myoglobin vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction. Clin Chem (1997) 1.19
Aldosterone induces angiotensin-converting-enzyme gene expression in cultured neonatal rat cardiocytes. Circulation (2001) 1.19
Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome. Am J Pathol (1990) 1.17
Purification and properties of uridine diphosphate N-acetylmuramate: L-alanine ligase. J Biochem (1973) 1.17
Increased 8-oxo-dGTPase in the mitochondria of substantia nigral neurons in Parkinson's disease. Ann Neurol (1999) 1.16
Distribution of mannosamine and mannosaminuronic acid among cell walls of Bacillus species. J Bacteriol (1982) 1.16
Mechanism of the rapid effect of 17 beta-estradiol on medial amygdala neurons. Science (1986) 1.15
Flavivirus encephalitis: pathological aspects of mouse and other animal models. Vet Pathol (2010) 1.15
Apparent reduction in the size of one side of the face associated with a small retrosplenial haemorrhage. J Neurol Neurosurg Psychiatry (1991) 1.15
Extended-release pramipexole in early Parkinson disease: a 33-week randomized controlled trial. Neurology (2011) 1.15
PARK9-linked parkinsonism in eastern Asia: mutation detection in ATP13A2 and clinical phenotype. Neurology (2008) 1.15
Cretinism with combined hormone deficiency caused by a mutation in the PIT1 gene. Nat Genet (1992) 1.15
Extended-release pramipexole in advanced Parkinson disease: a randomized controlled trial. Neurology (2011) 1.15
Oversecretion of IL-18 in haemophagocytic lymphohistiocytosis: a novel marker of disease activity. Br J Haematol (1999) 1.15
Glucose responding neurons in the nucleus tractus solitarius of the rat: in vitro study. Brain Res (1984) 1.15
Autologous transplantation of adipose tissue-derived stromal cells ameliorates pulmonary emphysema. Am J Transplant (2006) 1.14
Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitamin K2: possible implications for hip-fracture risk. Nutrition (2001) 1.13
Effects of chitin and its derivatives on the proliferation and cytokine production of fibroblasts in vitro. Biomaterials (1997) 1.12
Clinicopathologic study of a SNCA gene duplication patient with Parkinson disease and dementia. Neurology (2008) 1.12
Congenital choledochal cyst with intrahepatic involvement. Arch Surg (1984) 1.12
Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence. Biochem Biophys Res Commun (1990) 1.12
Activation of Sepharose with epichlorohydrin and subsequent immobilization of ligand for affinity adsorbent. J Biochem (1979) 1.12
Invasive and noninvasive thymoma: distinctive CT features. J Comput Assist Tomogr (2001) 1.11
Molecular cloning, gene expression, and identification of a splicing variant of the mouse parkin gene. Mamm Genome (2000) 1.11